Soluble thrombomodulin in patients with established atherosclerosis [6]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 1, 2004, Pages 200-201

  Gerdes, V E A ^a,b   Kremer Hovinga, J A ^b   ten Cate, H ^a,b   Brandjes, D P M ^a   Buller H R ^b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOMODULIN;

ADULT; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; B SCAN; BLOOD SAMPLING; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; LETTER; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERIPHERAL VASCULAR DISEASE; PREDICTION; PRIORITY JOURNAL; SOLUBILITY; ARTERIOSCLEROSIS; BLOOD; DIABETIC ANGIOPATHY; MIDDLE AGED;

ARTERIOSCLEROSIS; CEREBROVASCULAR ACCIDENT; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIPHERAL VASCULAR DISEASES; SOLUBILITY; THROMBOMODULIN;

EID: 4444335400     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.0562f.x     Document Type: Letter

References (7)

1. Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 1995; 9: 946-55.
2. Blann AD, Seigneur M, Steiner M, Boisseau MR, McCollum CN. Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest 1997; 27: 916-21.
3. Blann AD, Amiral J, McCollum CN. Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease. Eur J Haematol 1997; 59: 115-20.
4. Salomaa V, Matei C, Aleksic N, Sansores-Garcia L, Folsom AR, Juneja H, Chambless LE, Wu KK. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case - cohort study. Lancet 1999; 353: 1729-34.
5. Gerdes VEA, ten Cate H, de Groot E, Kwa VIH, Prins MH, Reitsma PH, Buller HR, Brandjes DPM. Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis. Atherosclerosis 2002; 163: 135-40.
6. Laszik ZG, Zhou XJ, Ferrell GL, Silva FG, Esmon CT. Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis. Am J Pathol 2001; 159: 797-802.
7. Schachinger V, Halle M, Minners J, Berg A, Zeiher AM. Lipoprotein(a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation. J Am Coll Cardiol 1997; 30: 927-34.